Utah Medical Products, Inc. (UTMD)
Utah Medical Products Market Cap: 188.11M for Jan. 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AIM ImmunoTech, Inc. | 3.648M |
| Perspective Therapeutics, Inc. | 188.08M |
| Protalix Biotherapeutics, Inc. | 162.45M |
| Electromed, Inc. | 231.78M |
| Armata Pharmaceuticals, Inc. | 227.79M |
Market Cap Related Metrics
| PE Ratio | 16.61 |
| PS Ratio | 4.997 |
| Price to Book Value | 1.591 |
| Price to Free Cash Flow | 13.91 |
| Price | 58.72 |
| Earnings Yield | 6.02% |
| Operating PE Ratio | 16.24 |
| Normalized PE Ratio | 16.61 |